The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity Academic Article uri icon

Overview

MeSH Major

  • Activin Receptors, Type II
  • Insulin Resistance
  • Muscle, Skeletal
  • Myostatin
  • Obesity

abstract

  • Our findings show that disruption of ActRIIB signaling is a viable pharmacological approach for treating obesity and diabetes.

publication date

  • August 12, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2783781

Digital Object Identifier (DOI)

  • 10.1038/ijo.2009.162

PubMed ID

  • 19668253

Additional Document Info

start page

  • 1265

end page

  • 73

volume

  • 33

number

  • 11